131
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Volume of embolic agents in uterine artery embolization for leiomyoma: relation to baseline MRI

, , &
Pages 186-193 | Received 04 Mar 2018, Accepted 16 Jul 2018, Published online: 27 Sep 2018

References

  • AbdElmagied AM, Vaughan LE, Weaver AL, et al. Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial. J Obstet Gynecol. 2016;215:338.e1–338.e18.
  • Sandberg EM, Tummers FHMP, Cohen SL, et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis. Fertil Steril. 2018;109:698–707.
  • Alkatout I, Mettler L, Günther V, et al. Safety and economical innovations regarding surgical treatment of fibroids. Minim Invasive Ther Allied Technol. 2016;25:301–313.
  • Alkatout I, Mettler L. Hysterectomy a comprehensive surgical approach. J Turkish German Gynecol Assoc. 2017;18:221–223.
  • Emanuel MH. Hysteroscopy and the treatment of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2015;29:920–929.
  • Vitale SG, Sapia F, Rapisarda AMC, et al. Hysteroscopic morcellation of submucous myomas: a systematic review. Biomed Res Int. 2017;2017:6848250
  • Bean EM, Cutner A, Holland T, et al. Laparoscopic myomectomy: a single-center retrospective review of 514 patients. J Minim Invasive Gynecol. 2017;24:485–493.
  • Gizzo S, Saccardi C, Patrelli TS, et al. Magnetic resonance-guided focused ultrasound myomectomy: safety, efficacy, subsequent fertility and quality-of-life improvements, a systematic review. Reprod Sci. 2014;21:465–476.
  • van Overhagen H, Reekers JA. Uterine artery embolization for symptomatic leiomyomata. Cardiovasc Intervent Radiol. 2015;38:536–542.
  • Dariushnia SR, Nikolic B, Stokes LAnn. S, et al. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. Society of interventional radiology standards of practice committee. J Vasc Interv Radiol. 2014;25:1737–1747.
  • Spies JB, Benenati JF, Worthington-Kirsch RL, et al. Initial experience with use of tris-acryl gelatin microspheres for uterine artery embolization for leiomyomata. J Vasc Interv Radiol. 2001;12:1059–1063.
  • Pelage J-P, Le Dref O, Beregi J-P, et al. Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol. 2003;14:15–20.
  • Spies JB, Allison S, Flick P, et al. Polyvinyl alcohol particles and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a randomized comparative study. J Vasc Interv Radiol. 2004;15:793–800.
  • Spies JB, Allison S, Flick P, et al. Spherical polyvinyl alcohol versus tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a limited randomized comparative study. J Vasc Interv Radiol. 2005;16:1431–1437.
  • Lohle PNM, Boekkooi FP, Smeets AJ, et al. Limited uterine artery embolization for leiomyomas with tris-acryl gelatin microspheres: 1-year follow-up. J Vasc Interv Radiol. 2006;17:283–287.
  • Siskin GP, Beck A, Schuster M, et al. Leiomyoma infarction after uterine artery embolization: a prospective randomized study comparing tris-acryl gelatin microspheres versus polyvinyl alcohol microspheres. J Vasc Interv Radiol. 2008;19:58–65.
  • Worthington-Kirsch RL, Siskin GP, Hegener P, et al. Comparison of the efficacy of the embolic agents acrylamide polynivyl alcohol microspheres and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: a prospective randomized controlled trial. Cardiovasc Intervent Radiol. 2011;34:493–501.
  • Duvnjak S, Ravn P, Green A, et al. Assessment of uterine fibroid infarction after embolization with tris-acryl gelatin microspheres. Cogent Medicine. 2017;4:1360543.
  • Shlansky-Goldberg RD, Rosen MA, Mondschein JI, et al. Comparison of polyvinyl alcohol microspheres and tris-acryl gelatin microspheres for uterine fibroid embolization: results of a single-center randomized study. J Vasc Interv Radiol. 2014;25:823–832.
  • Katsumori T, Miura H, Arima H, et al. Tris-acryl gelatin microspheres versus gelatin sponge particles in uterine artery embolization for leiomyoma. Acta Radiol. 2017;58:834–841.
  • Burn PR, McCall JM, Chinn RJ, et al. Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries. Radiology. 2000;214:729–734.
  • Jha RC, Ascher SM, Imaoka I, et al. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization. Radiology. 2000;217:228–235.
  • Kroencke TJ, Scheurig C, Poellinger A, et al. Uterine artery embolization for leiomyomas: percentage of infarction predicts clinical outcome. Radiology. 2010;255:834–841.
  • Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99:290–300.
  • Thrippleton MJ, Munro KI, McKillop G, et al. Unbiased and efficient estimation of the volume of the fibroid uterus using the Cavalieri method and magnetic resonance imaging. Reprod Sci. 2015;22:15–22.
  • Hovsepian DM, Siskin GP, Bonn J, et al. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. CIRSE committee; SIR standards of practice committee. J Vasc Interv Radiol. 2004;15:535–541.
  • Sutter O, Soyer P, Shotar E, et al. Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization. Eur Radiol. 2016;26:3558–3570.
  • Ruuskanen A, Sipola P, Hippeläinen M, et al. Pain after uterine fibroid embolization is associated with the severity of myometrial ischaemia on magnetic resonance imaging. Eur Radiol. 2009;19:2977–2985.
  • Lethaby A, Puscasiu L, Vollenhoven B. Preoperative medical therapy before surgery for uterine fibroids. Cochrane Database Syst Rev. 2017;11:CD000547.
  • Vitagliano A, Noventa M, Di Spiezio Sardo A, et al. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature. Arch Gynecol Obstet. 2018;297:823–835.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.